Performance standards for antimicrobial susceptibility testing: twenty-second informational supplement;[... provides updated tables for... M02-A11 and M07-A9].

Performance standards for antimicrobial susceptibility testing: twenty-second informational supplement;[... provides updated tables for... M02-A11 and M07-A9].
复制标题

DOI:
--
复制
发表时间:
2012
期刊:
--
影响因子:
--
通讯作者:
F. Cockerill
F. Cockerill
中科院分区:
其他
文献类型:
--
作者:
F. Cockerill

文献摘要

被引文献

相似文献

本文档中提供的补充信息旨在与以下临床和实验室标准协会(CLSI)批准的标准中公布的抗菌药物敏感性测试程序一起使用:m02 - a11 -抗菌药片敏感性测试性能标准;批准标准-第11版;和m07 - a9 -好氧生长细菌稀释药敏试验方法;批准标准第九版。该标准包含关于需氧细菌的圆盘(M02)和稀释(M07)测试程序的信息。临床医生在治疗重症患者时严重依赖临床微生物实验室的信息。抗菌药物敏感性试验结果的临床重要性要求在最佳条件下进行这些试验,并要求实验室有能力提供最新抗菌药物的结果。这里提供的表格信息代表了使用最新版本M02、M07和M11标准化程序进行药物选择、解释和质量控制的最新信息。用户应该用这些新表替换之前发布的表。(自最新版本以来的表更改以黑体字显示。)临床和实验室标准协会。药敏试验性能标准;第二十二份资料补编。CLSI文件M100-S22 (ISBN 1-56238-785-5[打印];ISBN 1-56238-786-3[电子])。临床和实验室标准协会,西谷路950号,2500室,韦恩,宾夕法尼亚州,19087,美国,2012年。只有在符合m02 - a11《抗菌药片药敏试验性能标准》方法的情况下,本补充解释表中的数据才有效;批准标准-第11版;和M07-A9 -需氧生长细菌稀释抗菌素敏感性试验方法;遵循批准的标准-第九版。2012年1月M100-S22
The supplemental information presented in this document is intended for use with the antimicrobial susceptibility testing procedures published in the following Clinical and Laboratory Standards Institute (CLSI)–approved standards: M02-A11—Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Eleventh Edition; and M07-A9—Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Ninth Edition. The standards contain information about both disk (M02) and dilution (M07) test procedures for aerobic bacteria. Clinicians depend heavily on information from the clinical microbiology laboratory for treatment of their seriously ill patients. The clinical importance of antimicrobial susceptibility test results requires that these tests be performed under optimal conditions and that laboratories have the capability to provide results for the newest antimicrobial agents. The tabular information presented here represents the most current information for drug selection, interpretation, and quality control using the procedures standardized in the most current editions of M02, M07, and M11. Users should replace the tables published earlier with these new tables. (Changes in the tables since the most current edition appear in boldface type.) Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. CLSI document M100-S22 (ISBN 1-56238-785-5 [Print]; ISBN 1-56238-786-3 [Electronic]). Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087 USA, 2012. The data in the interpretive tables in this supplement are valid only if the methodologies in M02-A11—Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Eleventh Edition; and M07-A9— Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Ninth Edition are followed. January 2012 M100-S22